(Q43958481)

28 November 2017

Effects of diabetes, vanadium, and insulin on glycogen synthase activation in Wistar rats (English)

1 reference

28 November 2017

2

1 reference

28 November 2017

Sabina Semiz

1

1 reference

PubMed ID

11952162

28 November 2017

John H McNeill

series ordinal

3

1 reference

28 November 2017

1 February 2002

1 reference

Molecular and Cellular Biochemistry

28 November 2017

1 reference

28 November 2017

231

1 reference

28 November 2017

1-2

1 reference

28 November 2017

23-35

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1014437019586

28 November 2017

0 references

cites work

Signal transduction: Life, the universe and ... development

1 reference

12 December 2020

Multisite phosphorylation of glycogen synthase from rabbit skeletal muscle. Phosphorylation of site 5 by glycogen synthase kinase-5 (casein kinase-II) is a prerequisite for phosphorylation of sites 3 by glycogen synthase kinase-3

1 reference

12 December 2020

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

12 December 2020

Insulin receptor function and glycogen synthase activity in skeletal muscle biopsies from patients with insulin-dependent diabetes mellitus: effects of physical training

1 reference

12 December 2020

Vanadate normalizes hyperglycemia in two mouse models of non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Phosphorylation of sites 3a and 3b (Ser640 and Ser644) in the control of rabbit muscle glycogen synthase

1 reference

12 December 2020

Insulin activates protein kinase B, inhibits glycogen synthase kinase-3 and activates glycogen synthase by rapamycin-insensitive pathways in skeletal muscle and adipose tissue

1 reference

12 December 2020

Inhibition of glycogen synthase kinase-3 by insulin in cultured human skeletal muscle myoblasts

1 reference

12 December 2020

Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus: in vivo and in vitro studies

1 reference

12 December 2020

Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats

1 reference

12 December 2020

Protein Phosphatase-1 and -2A Activities in Heart, Liver, and Skeletal Muscle Extracts from Control and Diabetic Rats

1 reference

12 December 2020

In vivo effects of insulin and bis(maltolato)oxovanadium (IV) on PKB activity in the skeletal muscle and liver of diabetic rats

1 reference

12 December 2020

Glycogen synthase from rabbit skeletal muscle; effect of insulin on the state of phosphorylation of the seven phosphoserine residues in vivo

1 reference

12 December 2020

The α-isoform of glycogen synthase kinase-3 from rabbit skeletal muscle is inactivated by p70 S6 kinase or MAP kinase-activated protein kinase-1 in vitro

1 reference

12 December 2020

Correction of chronic hyperglycemia with vanadate, but not with phlorizin, normalizes in vivo glycogen repletion and in vitro glycogen synthase activity in diabetic skeletal muscle

1 reference

12 December 2020

13C/31P NMR studies on the mechanism of insulin resistance in obesity

1 reference

12 December 2020

Glucose-lowering effects of a new organic vanadium complex, bis(maltolato)oxovanadium(IV)

1 reference

12 December 2020

Mitogen-activated S6 kinase is stimulated via protein kinase C-dependent and independent pathways in Swiss 3T3 cells

1 reference

12 December 2020

Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Glycogen synthase and phosphofructokinase protein and mRNA levels in skeletal muscle from insulin-resistant patients with non-insulin-dependent diabetes mellitus.

1 reference

12 December 2020

Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice

1 reference

12 December 2020

Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes

1 reference

12 December 2020

General characteristics of the insulin resistance syndrome: prevalence and heritability. European Group for the study of Insulin Resistance (EGIR).

1 reference

12 December 2020

Protein phosphatase-1 and insulin action.

1 reference

12 December 2020

An insulin-stimulated ribosomal protein S6 kinase from rabbit liver

1 reference

12 December 2020

Metabolic effects of sodium metavanadate in humans with insulin-dependent and noninsulin-dependent diabetes mellitus in vivo and in vitro studies

1 reference

12 December 2020

An improved procedure for identifying and quantitating protein phosphatases in mammalian tissues

1 reference

12 December 2020

Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats. Characterization and mode of action

1 reference

12 December 2020

In vivo regulation of protein-serine kinases by insulin in skeletal muscle of fructose-hypertensive rats

1 reference

12 December 2020

The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle

1 reference

12 December 2020

Vanadate restores glucose 6-phosphate in diabetic rats: a mechanism to enhance glucose metabolism

1 reference

12 December 2020

Oral treatment with vanadium of Zucker fatty rats activates muscle glycogen synthesis and insulin-stimulated protein phosphatase-1 activity

1 reference

12 December 2020

Glucose transport and NIDDM

1 reference

12 December 2020

Activation of glycogen synthase in rat adipocytes by insulin and glucose involves increased glucose transport and phosphorylation

1 reference

12 December 2020

A specific immunoprecipitation assay for the protein kinase FA/glycogen synthase kinase 3

1 reference

12 December 2020

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

1 reference

12 December 2020

Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase

1 reference

12 December 2020

Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B.

1 reference

12 December 2020

Acute and chronic oral administration of bis(maltolato)oxovanadium(IV) in Zucker diabetic fatty (ZDF) rats

1 reference

12 December 2020

The molecular mechanism by which adrenalin inhibits glycogen synthesis

1 reference

12 December 2020

Insulin-mediated effect on the activity of UDPG-glycogen transglucosylase of muscle

1 reference

12 December 2020

Expression of glycogen synthase and phosphofructokinase in muscle from type 1 (insulin-dependent) diabetic patients before and after intensive insulin treatment.

1 reference

12 December 2020

Glycogen synthase: activation by insulin and effect of transgenic overexpression in skeletal muscle

1 reference

12 December 2020

Molecular cloning and expression of glycogen synthase kinase-3/factor A

1 reference

12 December 2020

Insulin-mediated glycogen synthase activity in muscle of spontaneously insulin-resistant and diabetic rhesus monkeys

1 reference

12 December 2020

Characterization of insulin-stimulated seryl/threonyl protein kinases in rat skeletal muscle

1 reference

12 December 2020

Natural course of insulin resistance in type I diabetes.

1 reference

12 December 2020

Distinct glucose lowering and beta cell protective effects of vanadium and food restriction in streptozotocin-diabetes

1 reference

12 December 2020

Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes

1 reference

12 December 2020

Tyrosine dephosphorylation of glycogen synthase kinase-3 is involved in its extracellular signal-dependent inactivation

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1014437019586

1 reference

PubMed ID

11952162

Dimensions Publication ID

28 November 2017

0 references

1 reference

PubMed ID

11952162